Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. (Q53276288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

sickle-cell disease

0 references

pulmonary hypertension

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Kenneth I Ataga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Julia E Brittain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Susan K Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ryan May

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

John Delaney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Dell Strayhorn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Rupa Redding-Lallinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nigel S Key

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eugene P Orringer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

11 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Haematology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

485-491

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21223248%20AND%20SRC:MED&resulttype=core&format=json

Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Placenta growth factor in sickle cell disease: association with hemolysis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Managing patients treated with bevacizumab combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Increased serum levels of anti-angiogenic factors soluble fms-like tyrosine kinase and soluble endoglin in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Placenta growth factor activates monocytes and correlates with sickle cell disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Thrombotic events in patients with cancer receiving antiangiogenesis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X

Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2010.08410.X